Switzerland shows sustained growth of biotech sector
The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.
Replacing beef with cellular protein halves deforestation
Replacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions.
Commission to establish EU health data space
Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.
Four new autoantigens trigger multiple sclerosis
Swiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice.
TWB partners with Processium and Syngulon
Industrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon.
Meat consumption must fall by at least 75 percent
If our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers.
Vigeneron updates gene therapy collab with Daiichi Sankyo
ViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo novel treatment of prevalent eye diseases.
Single-use market to reach $20.8bn by 2026
Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product.
Study shows advantages of cellular agriculture
Novel foods derived from cell culture instead of animals reduce the environmental impact of diets, water and land use by 80%, report Finnish researchers.
EMA delays Valneva vaccine approval
The approval of Valneva’s Corona vaccine is delaying. The European Medicines Agencys CHMP requested additional data.